[Skin manifestations in monocytic leukemia].
D000038:Abscess / Q000209:etiology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006651:Histocytochemistry; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D009336:Necrosis / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D012790:Shwartzman Phenomenon / Q000209:etiology*; D012877:Skin Manifestations
D000970:Antineoplastic Agents; D015122:Mercaptopurine; D011241:Prednisone
Hautveränderungen bei Monozytenleukose.